AzTrials
AzTrials

Mental DiseaseEAT-HOPENCT07453355

EXPRESSIVE ARTS THERAPY FOR HOPE IN PEOPLE WITH SCHIZOPHRENIA

A study testing Expressive Arts Therapy in people with Mental Disease and şizofreni, run by Ondokuz Mayıs University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled trial aimed to evaluate the effectiveness of an expressive arts therapy programme based on positive psychotherapy principles in strengthening hope among individuals diagnosed with schizophrenia. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Mental Disease, şizofreni
What is being tested?
Expressive Arts Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteTurkey (Türkiye)
Study dates
22 Jul 2025to 13 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosis of schizophrenia according to clinical evaluation
  • Age between 18 and 65 years
  • Hospitalized in a psychiatric inpatient unit
  • At least six months since diagnosis
  • Ability to read and understand assessment tools
  • Clinically stable without acute psychotic symptoms
  • Provided written informed consent

Who cannot join

  • Severe cognitive impairment
  • Acute psychotic symptoms requiring intensive treatment
  • Severe physical illness preventing participation
  • Refusal to participate or withdrawal of consent

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • samsun Mental Health Hospital

    Atakent, Samsun, 55200

Other trials in Turkey (Türkiye)

About this study

Official title: The Role of Expressive Arts Therapy in Strengthening Hope in Individuals With Schizophrenia: A Randomized Controlled Trial (EAT-HOPE)

This randomized controlled trial aimed to evaluate the effectiveness of an expressive arts therapy programme based on positive psychotherapy principles in strengthening hope among individuals diagnosed with schizophrenia. Hope is a central component of recovery in schizophrenia, yet structured nursing interventions specifically targeting hope remain limited.

The study was conducted with 50 inpatients diagnosed with schizophrenia at a mental health hospital in Türkiye. Participants were randomly assigned to either an intervention group or a control group. The intervention group participated in an eight-session expressive arts therapy programme delivered in small groups, while the control group received standard psychiatric care.

Read more

Hope levels were assessed before and after the intervention using the Herth Hope Scale. The findings demonstrated that participants who received expressive arts therapy showed significant improvements in overall hope and its key dimensions, including future orientation, positive readiness and expectancy, and connectedness, compared with those receiving standard care.

This study suggests that expressive arts therapy may be an effective recovery-oriented nursing intervention to strengthen hope and support psychological recovery in individuals with schizophrenia.

Read the detailed description

Schizophrenia is a chronic psychiatric disorder that significantly affects individuals' functioning, quality of life, and recovery processes. Hope has been identified as a central component of recovery in individuals with schizophrenia, as it supports coping, motivation, and engagement with treatment. However, structured psychosocial and nursing interventions specifically targeting hope remain limited.

Expressive arts therapy is a therapeutic approach that integrates creative expression processes such as drawing, collage, storytelling, and metaphor work to facilitate emotional expression, self-awareness, and psychological healing. Within psychiatric nursing, expressive arts therapy may offer a recovery-oriented approach that helps individuals express their experiences, reconstruct meaning, and strengthen hope.

This randomized controlled trial aimed to evaluate the effectiveness of an expressive arts therapy programme based on positive psychotherapy principles in strengthening hope among individuals diagnosed with schizophrenia. The study was conducted with 50 inpatients diagnosed with schizophrenia in a mental health hospital in Türkiye. Participants were randomly assigned to either an intervention group or a control group using a computer-generated randomization list prepared by an independent statistician.

Participants in the intervention group received an eight-session expressive arts therapy programme delivered face-to-face in small groups in addition to standard psychiatric care. Each session included psychoeducation, creative expression activities (such as drawing, collage, storytelling, and metaphor work), and group sharing processes aimed at strengthening emotional expression and hope. The control group received standard psychiatric inpatient care only.

Hope levels were assessed before and after the intervention using the Herth Hope Scale. The primary outcome of the study was the change in hope level measured by the Herth Hope Scale total score. Secondary outcomes included changes in the scale's subdimensions, including future orientation, positive readiness and expectancy, and interconnectedness.

The findings of this study are expected to contribute to the development of recovery-oriented psychosocial nursing interventions for individuals with schizophrenia and to provide evidence regarding the effectiveness of expressive arts therapy in strengthening hope.

Being tested
Expressive Arts Therapy
Keywords
Expressive Arts Therapy, Art Therapy, Hope, Psychiatric Nursing, Psychosocial Intervention, Randomized Controlled Trial, Positive Psychotherapy
Medical subject headings
Mental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Expressive Arts TherapyBehavioural

    Intervention Description (Kopyalayın)

    An expressive arts therapy programme based on positive psychotherapy principles was delivered in small groups. The programme consisted of eight structured sessions conducted face-to-face. Each session included psychoeducation, creative expression activities such as drawing, collage, storytelling, and metaphor work, and group sharing. The intervention aimed to strengthen hope, enhance emotional expression, and support psychological recovery in individuals with schizophrenia.

Study groups in NCT07453355
Study groupRoleWhat they receive
Expressive Arts Therapy GroupExperimentalParticipants in this arm received an expressive arts therapy programme based on positive psychotherapy principles in addition to standard psychiatric care. The programme consisted of eight structured group sessions delivered face-to-face in small groups. Each session included psychoeducation, creative expression activities such as drawing, collage, and metaphor work, and group sharing. The intervention aimed to strengthen hope and support psychological recovery.
Receives: Behavioral: Expressive Arts Therapy
Control GroupNo interventionParticipants in this arm received standard psychiatric inpatient care only. Standard care included routine pharmacological treatment, clinical monitoring, and nursing care. No additional psychosocial or expressive arts therapy intervention was provided during the study period.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Hope Level Measured by the Herth Hope Scale

    Hope level will be assessed using the Herth Hope Scale (HHS), a validated 12-item self-report instrument with scores ranging from 12 to 48. Higher scores indicate higher levels of hope.

    Measured: Baseline and immediately after completion of the intervention (4 weeks)

  2. Herth Hope Scale

    Changes in Herth Hope Scale subscale scores (future orientation, positive readiness and expectancy, and interconnectedness) will be evaluated.

    Measured: Baseline and immediately after completion of the 8-session intervention (approximately 4 weeks)

Secondary outcomes (1)
  1. Change in Herth Hope Scale Subscale Scores

    Changes in the subscale scores of the Herth Hope Scale, including future orientation, positive readiness and expectancy, and interconnectedness, will be evaluated.

    Measured: Baseline and immediately after completion of the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Mar 2026
  2. Study start22 Jul 2025
  3. Primary completion30 Oct 2025
  4. Study completion13 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants were randomly assigned in a 1:1 ratio to either the expressive arts therapy intervention group or the control group using a computer-generated randomization list prepared by an independent statistician. The intervention group received an eight-session expressive arts therapy programme delivered in small groups, in addition to standard psychiatric care. The control group received standard psychiatric care only. Outcome measures were assessed at baseline and immediately after completion of the intervention. The study followed a parallel-group design, and the data analyst was blinded to group allocation.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07453355
Sponsor's protocol ID
OMU-SCH-EAT-RCT-2025
Other IDs
OMU-ETHICS-2024-1305
Acronym
EAT-HOPE
Status last verified
Mar 2026
First submitted
1 Mar 2026
Last updated
10 Mar 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be publicly shared due to privacy and confidentiality considerations involving a vulnerable psychiatric population. De-identified data may be made available from the principal investigator upon reasonable request and with appropriate ethical approval.

Questions about this trial

What is this clinical trial studying?

A study testing Expressive Arts Therapy in people with Mental Disease and şizofreni, run by Ondokuz Mayıs University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Hope Level Measured by the Herth Hope Scale (time frame: Baseline and immediately after completion of the intervention (4 weeks)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in